Find and Pitch Jounalists, Get Your Story Covered

Tags: Multiple Myeloma Regimen Comparisons Pharmacist Treatment Selection advice

	Profile	Recent Articles on Subject
1	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Better Quality of Life With RT vs Endocrine Therapy in Older Breast Cancer Patients - 12 days ago Palbociclib Regimen Yields 'Incredible' PFS Gain in Metastatic Breast Cancer - 13 days ago RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLC - about 1 year ago
2	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Fixed-Duration Acalabrutinib and Venetoclax Regimens Redefine First-Line Treatment Options for Patients With CLL - 17 days ago Ibrutinib Plus Venetoclax With MRD-Directed Duration of Treatment Is a New Standard-of-Care Regimen for Previously Unmanaged CLL - 11 months ago Ibrutinib Plus Venetoclax With MRD-Directed Duration of Treatment Is a New Standard of Care Regimen for Previously Untreated CLL - about 1 year ago Assessing Clinical Trial Efficacy vs Real-World Effectiveness in the Treatment of Multiple Myeloma - about 1 year ago Oncology Pharmacists “Approve Every Regimen That Gets Built Into the Oncology EMR,” yet Pharma Often Overlooks Their Role - about 1 year ago
3	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Data Further Confirm Proposed Denosumab Biosimilar Shows Similar Efficacy to Originator - 24 days ago Financial Incentives Increase Utilization of Biosimilars for Oncology Care - 30 days ago Clinical Safety Data Show Switching Between Rituximab Biosimilars Does Not Increase Adverse Events - about 1 month ago Non-Medical Switch to Infliximab Biosimilar Demonstrates Similar Outcomes for IBD - 3 months ago Intermittent Fasting and Meal Replacements Improved Short-Term Glycemia - 5 months ago Better Prevention Strategies Rely on the Monitoring of Outpatient Adverse Drug Events - 5 months ago INHALE-3 Study Data Shows Diabetes Care Is Not “One-Size-Fits-All” - 6 months ago Study: Biosimilar Competition Did Not Consistently Lower Costs for Patients - 9 months ago Dostarlimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit in Endometrial Cancer - 9 months ago Experts Establish First Performance Measures of Lifestyle Medicine Treatments - 9 months ago Study: SB17 Shows Biosimilarity to Ustekinumab for Plaque Psoriasis - 10 months ago STRONG-HF: High-Intensity Care Leads to Higher Doses of Guideline Heart Failure Therapy - 12 months ago Study: Telemonitoring After Heart Failure Comparable to Standard of Care - about 1 year ago Domvanalimab-Containing Regimen Shows Positive Preliminary Data for Upper Gastrointestinal Cancers - about 1 year ago Study: No Difference Found in Safety of Reference Biologic, Biosimilar - about 1 year ago
4	The Conversation Science Alert Science news. Official account. Australia science news	Ozempic vs Supplements: Dietitian Reveals Truth About GLP-1 Imitations - 28 days ago
5	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about a key Merck drug trial, cheap Wegovy in China, and more - about 1 month ago STAT+: Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more - 9 months ago STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies - 10 months ago STAT+: Health plan formularies lowered barriers to fair access to some drugs, analysis finds - about 1 year ago
6	Tara Haelle MedPage Today Sci/health journalist. Feminist. Educator. Photographer. Author. DFW science journalismhealthphotographyteaching	ObesityWeek Roundup: Patients More Likely to Ration Obesity Drugs - about 1 month ago
7	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Daily Oral Edaravone for ALS No Better Than On/Off Regimen - 2 months ago
8	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	Treatment Regimen Considerations - 3 months ago Treatment Opportunities Continue to Advance in CLL Management - about 1 year ago
9	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	2-Drug Regimen Shows Comparable Effectiveness With 3-Drug Regimen to Treat HIV-1 - 5 months ago Durvalumab Shows Improvements in Overall Survival, Progression-Free Survival for Small Cell Lung Cancer - 9 months ago Dramatic Tumor Regression Was Displayed in New Approach to CAR T Therapy - 9 months ago Researchers Compare Reimbursement and Access to New Treatments in European Lung Cancer Care - 10 months ago
10	Kristen Monaco MedPage Today	Digital Therapies Compared; Summertime Sadness? Spravato Monotherapy Under Review - 5 months ago Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 5 months ago Surgery May Be More Cost-Effective Than Wegovy in Adults With a BMI 35+ - 9 months ago Primary Care Strategy Fails to Reduce Kidney-Dysfunction Triad Hospitalizations - 9 months ago Some 'Choosing Wisely' Recs Protect Older Folks From Low-Value Care - 11 months ago

Journalists covering Regimen Comparisons